本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corvus Pharmaceuticals, Inc.

15.04
-0.0700-0.46%
盤後15.040.00000.00%19:11 EDT
成交量:63.25萬
成交額:948.25萬
市值:12.60億
市盈率:-28.38
高:15.29
開:15.21
低:14.68
收:15.11
52周最高:26.95
52周最低:3.11
股本:8,376.77萬
流通股本:6,719.80萬
量比:0.80
換手率:0.94%
股息:- -
股息率:- -
每股收益(TTM):-0.5300
每股收益(LYR):-0.5320
淨資產收益率:-32.60%
總資產收益率:-38.36%
市淨率:20.58
市盈率(LYR):-28.27

資料載入中...

2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/30

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/03

重要事件披露

8-K - Current report
2022/11/03

重要事件披露

8-K/A [Amend] - Current report
2022/10/28

重要事件披露

8-K - Current report
2022/08/08

重要事件披露

8-K - Current report
2022/08/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/17

重要事件披露

8-K - Current report
2022/05/05

重要事件披露

8-K - Current report
2022/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/10

重要事件披露

8-K - Current report
2022/03/10

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/18

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/06

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals